Radiation-induced second malignancies

Journal of Palliative Medicine

Volumn 11, Issue 10, 2008, Pages 1345-1352

  Walton, Abigail ^a   Broadbent, Andrew L ^a,b  

^a Greenwich Hospital   (Australia)

^b Palliative Care   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FENTANYL; TRANEXAMIC ACID;

AGED; ANGIOSARCOMA; ARTICLE; BLEEDING; BLISTER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; ERYTHEMA; FEMALE; FIBROCYSTIOCYTOMA; HUMAN; MASTECTOMY; PAIN; RADIATION CARCINOGENESIS; RADIATION INJURY; SECOND CANCER; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; NEOPLASMS, RADIATION-INDUCED; PALLIATIVE CARE;

EID: 58149216647     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2008.9815     Document Type: Article

References (84)

1. Ron E: Cancer risks from medical radiation. Health Physics 2003;85:47-59.
2. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH: Cancer survivorship - Genetic susceptibility and second primary cancers: Research strategies and recommendations. J Nati Cancer Inst 2006;98:15-25.
3. Deutsch M, Safyan E: Angiosarcoma of the breast occurring soon after lumpectomy and breast irradiation for infiltrating ductal carcinoma: a case report. Am J Clin Oncol 2003;26:471-472.
4. Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA: Clinicopathologic features and treatment of post-irradiation sarcoma of bone and soft tissue. J Surg Oncol 2000;75:42-50.
5. Bradley J: Radiation-induced tumors of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2002;10:97-103.
6. van der Laan BF, Baris G, Gregor RT, Hilgers FJ, Balm AJ: Radiation-induced tumors of the head and neck. J Laryngol Otol 1995;109:346-349.
7. Edeiken S, Russo DP, Knecht J, Parry LA, Thompson RM: Angiosarcoma after tylectomy and radiation therapy for carcinoma of the breast. Cancer 1992;70:644-647.
8. Chudecki B: Radiation cancer of the thoracic oesophagus. Br J Radiol 1972;45:303-304.
9. Cahan WG, Woodward HQ, Higginbothan NL: Sarcoma arising in irradiated bone: report of 11 cases. Cancer 1948:23-29.
10. Warren S, Gates O: Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932;16:1358-1414.
11. Etzel RA: Risk of ionizing radiation exposure to children: A subject review. American Acadademy of Pediatrics. Committee on Environmental Health. Pediatrics 1998;101(4 Pt 1):717-719.
12. Travis LB: Therapy-associated solid tumors. Acta Oncologica 2002;41:323-333.
13. Haupt S, Haupt Y: Importance of p53 for cancer onset and therapy. Anticancer Drugs 2006;17:725-732.
14. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV: A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy [see comment]. Science 1999;285:1733-1737.
15. Gonin-Laurent N, Gibaud A, Huygue M, Lefevre SH, Le Bras M, Chauveinc L, Sastre-Garau X, Doz F, Lumbroso L, Chevillard S, Malfoy B: Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis 2006;27: 1266-1272.
16. Lorimore SA, Coates PJ, Wright EG: Radiation-induced genomic instability and bystander effects: Inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003;22:7058-7069.
17. Lagrange JL, Ramaioli A, Chateau MC, Marchal C, Resbeut M, Richaud P, Lagarde P, Rambert P, Tortechaux J, Seng SH, de la Fontan B, Reme-Saumon M, Bof J, Ghnassia JP, Coindre JM: Sarcoma after radiation therapy: Retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology 2000;216:197-205.
18. Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJ: Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforseen sequela [see comment]. Breast Cancer Res Treat 1998;47:101-109.
19. Zucali R, Merson M, Placucci M, Di Palma S, Veronesi U: Soft tissue sarcoma of the breast after conservative surgery and irradiation for early mammary cancer. Radiother Oncol 1994;30:271-273.
20. Molitor JL, Llombart A, Guinebretiere JM, Zemoura L, Spielmann M, Contesso G, de Vathaire F, Zelek L, Kaylitalire L, Le Chevalier T, Genin J: [Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]. Bull Cancer 1997;84:206-221.
21. Kirova YM, Feuilhade F, Calitchi E, Otmezguine Y, Belembaogo E, Le Bourgeois JP: [Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature]. Cancer Radiother 1998;2:381-386.
22. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, Diallo I, Vassal G, Bessa E, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Eschwège F, Chavaudra J, Lemerle J: Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 1998;77:370-377.
23. Badwe RA, Hanby AM, Fentiman IS, Chaudary MA: Angiosarcoma of the skin overlying an irradiated breast. Breast Cancer Res Treat 1991;19:69-72.
24. Fineberg S, Rosen PP: Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. Am J Clin Pathol 1994; 102:757-763.
25. Bolin DJ, Lukas GM: Low-grade dermal angiosarcoma of the breast following radiotherapy. Am Surg 1996;62:668-672.
26. Wijnmaalen A, van Ooijen B, van Geel BN, Henzen-Logmans SC, Treurniet-Donker AD: Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: Three case reports and a review of the literature. Int J Radiat Oncol Biol Physics 1993;26:135-139.
27. Cafiero F, Gipponi M, Peressini A, Queirolo P, Bertoglio S, Comandini D, Percivale P, Sertoli MR, Badellino F: Radiation-associated angiosarcoma: Diagnostic and therapeutic implications-Two case reports and a review of the literature [see comment]. Cancer 1996;77:2496-502.
28. Stokkel MP, Peterse HL: Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma [see comment]. Cancer 1992;69:2965-2968.
29. Body G, Sauvanet E, Calais G, Fignon A, Fetissof F, Lansac J: [Cutaneous angiosarcoma of the breast following surgery and irradiation of breast adenocarcinoma]. J Gynecol Obstet Biol Reprod (Paris) 1987;16:479-483.
30. Kuten A, Sapir D, Cohen Y, Haim N, Borovik R, Robinson E: Postirradiation soft tissue sarcoma occurring in breast cancer patients: Report of seven cases and results of combination chemotherapy. J Surg Oncol 1985;28:168-171.
31. Lawton J: The Dying Process: Patient's Experiences of Palliative Care. London: Routledge, 2000.
32. Collier M: Management of patients with fungating wounds. Nurs Stand 2000;15:46, 48-50, 52.
33. Wilkes LM, Boxer E, White K: The hidden side of nursing: Why caring for patients with malignant malodorous wounds is so difficult. J Wound Care 2003;12:76-80
34. Grocott P: Application of the principles of modern wound management for complex wounds. In: Proceedings of the First European Conference on the Advances of Wound Management. London: EMAP, 1992.
35. th World Congress on Pain. Seattle: IASP Press, 1994, pp. 285-297.
36. Grocott P: Care of patients with fungating malignant wounds. Nursing Standard 2007;21:57-58, 60, 62, 64, 66.
37. Kalinski C, Schnepf M, Laboy D, Hernandez L, Nusbaum J, McGrinder B, Comfort C, Alvarez OM: Effectiveness of a topical formation containing Metronidazole for wound odour and exudate control. Wounds 2005;17:84-90.
38. Bates-Jensen BM, Early L, Seam S: Skin disorders. In: Ferrel BR, Coyle N (eds): Textbook of Palliative Nursing. New York: Oxford University Press, 2001, pp. 204-244.
39. Grocott P: Malignant wounds.2004. In: Sykes N, Edmunds P, Wiles J (eds): Management of Advanced Disease, 4th ed. London: Hodder Arnold Publication, 2004, pp. 295-305.
40. Thomas S, Fisher B, Fram PJ, Waring MJ. 1998. Odour absorbing dressings: A comparative lab study. www.worldwidewounds./ 1998/march/Odour-Absorbing- Dressings/ odour-absorbing-dressings.html (Last accessed November 18, 2008).
41. Cooper R, Molan P: The use of honey as an antiseptic in managing Pseudomonas infection. J Wound Care 1999;8: 161-164.
42. Tice M: Wound care in the face of life-limiting illness. Home Healthc 2006;24:115-118.
43. th ed. Oxford: Radcliffe Medical Press, 2003.
44. Naylor W, Laverty D, Mallet J (eds): The Royal Marsden Hospital Handbook of Wound Management in Cancer Care. London: Blackwell Science, 2001.
45. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B: Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 2005;23:6126-6131.
46. Rubino C, Shamsaldin A, Le MG, Labbe M, Guinebretiere JM, Chavaudra J, de Vathaire F: Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 2005;89:277-288.
47. Stone HB, Coleman CN, Anscher MS, McBride WH: Effects of radiation on normal tissue: Consequences and mechanisms. Lancet Oncology 2003;4:529-536.
48. Dasu A, Toma-Dasu I, Olofsson J, Karlsson M: The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 2005;44:339-347.
49. Fowler JF: The first James Kirk memorial lecture. What next in fractionated radiotherapy? Br J Cancer Suppl 1984;6: 285-300.
50. Thames HD, Jr., Withers HR, Peters LJ, Fletcher GH: Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Physics 1982;8:219-226.
51. Mu X, Bjork-Eriksson T, Nill S, Oelfke U, Johansson KA, Gagliardi G, Johansson L, Karlsson M, Zackrisson DB: Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol 2005;44:554-562.
52. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Le MG: Increased risk of second cancers following breast cancer: Role of the initial treatment. Breast Cancer Res Treat 2000;61: 183-195.
53. Miller RW: Special susceptibility of the child to certain radiation-induced cancers. Environ Health Perspect 1995; 103(Suppl 6):41-44.
54. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr: Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 1995;14:259-277.
55. Mazonakis M, Damilakis J, Varveris H, Fasoulaki M, Gourtsoyiannis N: Risk estimation of radiation-induced thyroid cancer from treatment of brain tumors in adults and children. Int J Oncol 2003;22:221-225.
56. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC: Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993;77:362-369.
57. Clemons M, Loijens L, Goss P: Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 2000; 26:291-302.
58. Hall EJ, Brenner DJ, Worgul B, Smilenov L: Genetic susceptibility to radiation. Adv Space Res 2005;35:249-253.
59. McLeod HL, Krynetski EY, Relling MV, Evans WE: Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000;14:567-572.
60. Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, Tennis M, Czene K: Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design. J Clin Oncol 2005;23:7467-7474.
61. Rubin P: Late effects of cancer treatment: Radiation and drug toxicity. In: Perez CA, Halperin EC, Brady LW, Schmidt-Ullrich RK (eds): Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins, 1992, pp. 124-161.
62. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C: The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: A case-control study.[see comment]. Haematologica 1998;83:812-823.
63. Wendland MM, Tsodikov A, Glenn MJ, Gaffney DK: Time interval to the development of breast carcinoma after treatment for Hodgkin disease. Cancer 2004;101:1275-1282.
64. Roychoudhuri R, Evans H, Robinson D, Moller H: Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 2004;91:868-872.
65. Lundell M, Mattsson A, Hakulinen T, Holm LE: Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1996;145:225-230.
66. Rubino C, Adjadj E, Guerin S, Guibout C, Shamsaldin A, Dondon MG, Valteau-Couanet D, Hartmann O, Hawkins M, de Vathaire F: Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment. Int J Cancer 2003;107:791-796.
67. Guerin S, Dupuy A, Anderson H, Shamsaldin A, Svahn-Tapper G, Moller T, Quiniou E, Garwicz S, Hawkins M, Avril MF, Oberlin O, Chavaudra J, de Vathaire F: Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 2003;39:2379-2386.
68. Trefzer U, Voit C, Milling A, Audring H, Sterry W: Malignant melanoma arising in a radiotherapy field: Report of two cases and review of the literature. Dermatology 2003;206: 265-268.
69. Chopra KF, Cohen PR: Linear basal cell carcinomas: Report of multiple sequential tumors localized to a radiotherapy port and review of the literature. Texas Med 1997;93:57-59.
70. Maalej M, Frikha H, Kochbati L, Bouaouina N, Sellami D, Benna F, Gargouri W, Dhraief S, Nasr C, Daoud J, Hajji M, Fazaa B, Souissi R, Mokhtar I, Kamoun MR: Radio-induced malignancies of the scalp about 98 patients with 150 lesions and literature review. Cancer Radiother 2004;8:81-87.
71. Levi F, Moeckli R, Randimbison L, Te VC, Maspoli M, La Vecchia C: Skin cancer in survivors of childhood and adolescent cancer. Eur J Cancer 2006;42:656-659.
72. Lawson S, Som M: Second primary cancer after irradiation of laryngeal cancer. Ann Otol Rhinol Laryngol 1975;84:771-775.
73. Foster RS: Secondary tumors after initial successful treatment of metastatic testis cancer. Curr Opin Urol 1999;9: 443-445.
74. Park SS, Kim BK, Kim CJ, Kim WS, Kim IO, Park KW, Shin HY, Ahn HS: Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: A case report. J Korean Med Sci 2000;15: 475-477.
75. Sedghizadeh PP, Angiero F, Allen CM, Kalmar JR, Rawal Y, Albright EA: Post-irradiation leiomyosarcoma of the maxilla: Report of a case in a patient with prior radiation treatment for retinoblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:726-731.
76. Milde T, Alamo L, Stadelmann C, Schweigerer L, Witt O: Multifocal osteochondroma after repeated irradiation in a boy with Hodgkin disease. J Pediatr Hematol Oncol 2005;27:344-345.
77. Holmberg E, Wallgren A, Holm LE, Lundell M, Karlsson P: Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy. Radiat Res 2002; 158:418-423.
78. Arai T, Jobo T, Kawaguchi M, Kuramoto H: Aspiration cytology of malignant fibrous histiocytoma after radiation therapy for carcinoma of the uterine cervix: A case report. Acta Cytol 2004;48:859-863.
79. Ko JY, Chen CL, Lui LT, Hsu MM: Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996; 122:535-538.
80. Halpern J, Kopolovic J, Catane R: Malignant fibrous histiocytoma developing in irradiated sacral chordoma. Cancer 1984;53:2661-2662.
81. Bauduer F, Ducout L, Dastugue N, Marolleau JP: Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: A report of three cases and a brief review of the literature. Leuk Lymph 2002;43:1057-1060.
82. Nygaard R, Garwicz S, Haldorsen T, Hertz H, Jonmundsson GK, Lanning M, Moe PJ: Second malignant neoplasms in patients treated for childhood leukemia. A populationbased cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand 1991;80:1220-1228.
83. Micke O, Schafer U, Glashorster M, Prott FJ, Willich N: Radiation-induced esophageal carcinoma 30 years after mediastinal irradiation: Case report and review of the literature. Jpn J Clin Oncol 1999;29:164-170.
84. Fadl-Elmula I, Bonaldi L, Gorunova L, Mandahl N, Elfving P, Heim S: Cytogenetic heterogeneity in a second primary radiation-induced bladder carcinoma: Ten karyotypically unrelated clones. Cancer Genet Cytogenet 1998;105:134-137.